Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function
Condition(s):Renal ImpairmentLast Updated:November 27, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Renal ImpairmentLast Updated:November 27, 2019Completed
Condition(s):Renal ImpairmentLast Updated:October 19, 2012Completed
Condition(s):Hepatitis B, Chronic; Chronic Kidney DiseasesLast Updated:December 19, 2018Completed
Condition(s):COVID-19Last Updated:December 7, 2023Terminated
Condition(s):Chronic Kidney Disease; Renal Impairment; Healthy VolunteersLast Updated:August 21, 2023Completed
Condition(s):Hepatitis CLast Updated:July 10, 2014Completed
Condition(s):Renal ImpairmentLast Updated:April 8, 2020Completed
Condition(s):Improved Glycemic Control in Patients With Type 2 DiabetesLast Updated:March 23, 2022Unknown status
Condition(s):Renal ImpairmentLast Updated:March 11, 2022Completed
Condition(s):Renal ImpairmentLast Updated:August 2, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.